Corrigendum: Cell-Based Radiotracer Binding and Uptake Inhibition Assays: A Comparison of In Vitro Methods to Assess the Potency of Drugs That Target Monoamine Transporters

• Marija Ilic,
• Marija Ilic,
• Marija Ilic,
• Julian Maier,
• Marion Holy,
• Kathrin Jaentsch,
• Matthias E. Liechti,
• Gert Lubec,
• Michael H. Baumann,
• Harald H. Sitte,
• Dino Luethi,
• Dino Luethi

Affiliations

Marija Ilic

Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

Marija Ilic

Department of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Vienna, Austria

Marija Ilic

Neuroproteomics, Paracelsus Private Medical University, Salzburg, Austria

Julian Maier

Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

Marion Holy

Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

Kathrin Jaentsch

Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

Matthias E. Liechti

Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland

Gert Lubec

Neuroproteomics, Paracelsus Private Medical University, Salzburg, Austria

Michael H. Baumann

Designer Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, United States

Harald H. Sitte

Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

Dino Luethi

Institute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria

Dino Luethi

Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland